Pathogenesis of cystic fibrosis

[1]  A. Fomsgaard,et al.  Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients , 1992, Clinical and experimental immunology.

[2]  C. Higgins,et al.  Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein , 1992, Cell.

[3]  M. Welsh,et al.  Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. , 1992, Science.

[4]  Wendy L. Kimber,et al.  Cystic fibrosis in the mouse by targeted insertional mutagenesis , 1992, Nature.

[5]  R. Crystal,et al.  Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. , 1992, The Journal of clinical investigation.

[6]  Richard C. Boucher,et al.  Defective Epithelial Chloride Transport in a Gene-Targeted Mouse Model of Cystic Fibrosis , 1992, Science.

[7]  B. Koller,et al.  An Animal Model for Cystic Fibrosis Made by Gene Targeting , 1992, Science.

[8]  P. Gilligan,et al.  Nontuberculous mycobacteria in adult patients with cystic fibrosis. , 1992, Chest.

[9]  M. Corey,et al.  Genetic determination of exocrine pancreatic function in cystic fibrosis. , 1992, American journal of human genetics.

[10]  F. Collins,et al.  Cystic fibrosis: molecular biology and therapeutic implications. , 1992, Science.

[11]  M. White,et al.  Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. , 1992 .

[12]  J. Riordan,et al.  Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR) , 1992, Cell.

[13]  M. Corey,et al.  Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. , 1992, The Journal of clinical investigation.

[14]  N. Høiby,et al.  Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. , 1992, Thorax.

[15]  G. Cutting,et al.  Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. , 1992, American journal of human genetics.

[16]  S. Pedersen,et al.  Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. , 1992, APMIS. Supplementum.

[17]  J. Riordan,et al.  Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland , 1992, Nature Genetics.

[18]  J. Cohn,et al.  CFTR: development of high- affinity antibodies and localization in sweat gland. , 1991, Biochemical and biophysical research communications.

[19]  S. Cryz,et al.  Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis , 1991, The Lancet.

[20]  C. Higgins,et al.  Immunocytochemical localization of the cystic fibrosis gene product CFTR. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Buchwald,et al.  In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator , 1991, Nature.

[22]  N. Høiby,et al.  Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment , 1991, The Lancet.

[23]  R. Boucher,et al.  Transcellular sodium transport in cultured cystic fibrosis human nasal epithelium. , 1991, The American journal of physiology.

[24]  B. Thorsteinsson,et al.  Glucose tolerance in cystic fibrosis. , 1991, Archives of disease in childhood.

[25]  M. Schwartz,et al.  Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation , 1991, The Lancet.

[26]  M. Berger.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? , 1991, Clinical reviews in allergy.

[27]  R. Stern,et al.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis , 1990, The Lancet.

[28]  N. Høiby,et al.  Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management. , 1990, Thorax.

[29]  B. Petrini,et al.  Prospective study of mycobacterial infections in patients with cystic fibrosis. , 1990, Thorax.

[30]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.

[31]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[32]  J. Riordan,et al.  Identification of the Cystic Fibrosis Gene : Chromosome Walking and Jumping Author ( s ) : , 2008 .

[33]  M. Dodd,et al.  Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms. , 1989, Thorax.

[34]  N. HØiby,et al.  Estimated Risk of Cross‐Infection with Pseudomonas aeruginosa in Danish Cystic Fibrosis Patients , 1989, Acta paediatrica Scandinavica.

[35]  N. Høiby,et al.  Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients. , 1987, Antibiotics and chemotherapy.

[36]  L. Cantley,et al.  Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. , 1986, The Journal of clinical investigation.

[37]  P. Quinton,et al.  Chloride impermeability in cystic fibrosis , 1983, Nature.

[38]  N. Høiby,et al.  RESPIRATORY INFECTIONS IN CYSTIC FIBROSIS PATIENTS CAUSED BY VIRUS, CHLAMYDIA AND MYCOPLASMA–POSSIBLE SYNERGISM WITH PSEUDOMONAS AERUGINOSA , 1981, Acta paediatrica Scandinavica.